Nephros, Inc. (NEPH)


OTC BB - OTC BB Delayed Price. Currency in USD
0.40+0.02 (+5.26%)
At close: 3:37 PM EDT
People also watch:
BIELADLSNRIFFASFXLLBO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.41
Prev Close0.38
Bid0.00 x
Ask0.00 x
Day's Range0.38 - 0.44
52wk Range0.20 - 0.62
1y Target EstN/A
Market Cap19.23M
P/E Ratio (ttm)-5.33
Beta-1.44
Volume17,579
Avg Vol (3m)29,445
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Nephros, Inc. :NEPH-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016
    Capital Cube9 days ago

    Nephros, Inc. :NEPH-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016

    Categories: Yahoo Finance Get free summary analysis Nephros, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Nephros, Inc. – Rockwell Medical, Inc., Boston Scientific Corporation, Thermo Fisher Scientific Inc., Baxter International Inc., NxStage Medical, Inc., Mesa Laboratories, Inc. and Danaher Corporation (RMTI-US, BSX-US, TMO-US, BAX-US, ... Read more (Read more...)

  • Accesswire17 days ago

    Nephros Reports Second Quarter 2016 Financial Results

    RIVER EDGE, NJ / ACCESSWIRE / August 8, 2016 / Nephros, Inc. (OTCQB: NEPH), (the "Company") a commercial stage medical device company that develops and sells high performance liquid purification ...

  • Accesswire3 months ago

    Nephros Announces Closing of $1.2 Million Note and Warrant Offering

    RIVER EDGE, NJ / ACCESSWIRE / June 9, 2016 / Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ...